Johne’s Disease Diagnostics Market to Grow with a CAGR of 5.63% through 2028
Regional prevalence and collaborative efforts are
expected to drive the Global Johne’s Disease Diagnostics Market growth in the
forecast period, 2024-2028.
According to TechSci Research report, “Johne’s
Disease Diagnostics Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Johne’s
Disease Diagnostics Market stood at USD 0.63 billion in 2022 and is anticipated
to grow with a CAGR of 5.63% in the forecast period, 2024-2028. This can be
attributed to regional prevalence and disease management. The prevalence of
Johne's Disease varies by region, with some areas experiencing higher incidence
rates than others. Countries like the United States, Canada, Australia, and
parts of Europe have been particularly affected. As a result, the demand for
diagnostic tools is more pronounced in these regions. Regulatory authorities
and livestock producers in high-prevalence regions have recognized the
importance of comprehensive disease management strategies, which include
regular testing and early detection. In addition, the One Health approach,
which recognizes the interconnectedness of human, animal, and environmental
health, is gaining traction in the context of Johne's Disease diagnostics.
Collaborations and research that involve multiple disciplines are addressing
the broader implications of the disease and its potential impact on public
health.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Johne’s Disease Diagnostics Market.”
The global trend of digitalization in healthcare has
also made a significant impact on the animal health sector, including the field
of Johne's disease diagnostics. Companies are investing in product development
to enhance testing accuracy, validate devices, expand the range of available
tests, and automate processes wherever possible, simplifying device operation.
Point-of-care testing for infectious diseases, particularly those affecting
livestock or those with zoonotic potential, is emerging as a high-value target.
The COVID-19 pandemic had a notable negative effect on
the Johne's disease diagnostics market, especially in 2020. This downturn can
be primarily attributed to the closure of veterinary diagnostics facilities and
restricted access due to social distancing measures and lockdowns. However, as
governments began to ease stay-at-home policies during the second and third
quarters of 2020, demand gradually recovered. Challenges related to remote
collaboration and field testing efficiency were also encountered during the
pandemic. Nevertheless, the Johne's disease diagnostics market is expected to
experience significant growth in the coming years due to the increasing demand
for convenient and rapid diagnostic solutions and relatively relaxed regulatory
oversight. It's worth noting that the U.S. FDA does not mandate manufacturers
exclusively producing or marketing veterinary devices to list their devices or
register their establishments, contributing to market dynamics.
Several key drivers are influencing the Johne's
disease diagnostics market, including Johne's disease eradication initiatives,
heightened awareness about paratuberculosis, and the expanding livestock
population. For instance, the Irish Johne's Control Programme (IJCP) is a
voluntary, long-term program aimed at controlling Johne's disease in Ireland.
It is strongly supported by the Irish cattle industry and leverages the
establishment of Animal Health Ireland to combat diseases not covered by EU
regulations, with specific goals to prevent transmission, reduce infection
levels, ensure controlled markets, and promote calf health and farm
biosecurity. In the United States, the USDA's Animal and Plant Health
Inspection Service's Veterinary Services department (USDA-APHIS-VS) has
implemented a Johne's disease curtail program to limit the disease's spread to
non-infected herds. This program includes risk assessments, funding for
research on control measures, and cooperation among federal, state, and
industry stakeholders. The Johne's disease diagnostics market also benefits
from ongoing innovation in the veterinary diagnostics sector.
For example, Zoetis expanded its VETSCAN IMAGYST
platform by introducing Digital Cytology testing in September 2020 and further
enhancements in March 2022. This platform now offers access to remote clinical
diagnosticians and employs AI technology for fecal testing. In addition,
advancements in in-clinic digital cytology scanners from IDEXX and Antech are
improving diagnostic efficiency, client satisfaction, and connectivity between
veterinarians and pathologists, thereby advancing the veterinary medicine industry.
The Global Johne’s Disease Diagnostics Market is
segmented into animal type, test type, regional
distribution, and company.
Based on its animal type, the cattle sector emerged as
the dominant force in the market in 2022, commanding the largest share of
revenue. This category encompasses various bovine animals such as cows, bulls,
oxen, calves, and buffaloes. The anticipated increase in zoonotic disease
occurrences among cattle is expected to propel market expansion. According to
data from the National Library of Medicine, in 2019, out of the 1,407 known
human diseases, 816 were classified as zoonotic, indicating their potential to
naturally spread between animals and humans. These zoonotic diseases
encompassed 538 bacteria and rickettsia, 317 fungi, 208 viruses, 287 helminths,
and 57 protozoa. On a global scale, the burgeoning populations of cows and
livestock are contributing significantly to the expansion of this market.
France, boasting an impressive cattle population of
over 18 million in 2020, primarily focused on beef production. In the same
year, beef and pork collectively represented more than 80% of the entire cattle
farming landscape in France. It is worth noting that the sheep sector is poised
to experience the most rapid growth during the forecasted period. Ovine Johne’s
disease, which is caused by Mycobacterium paratuberculosis infection, is a key
factor driving this trend. In Australia, owners are required to promptly report
confirmed or suspected cases of ovine Johne’s disease to Agriculture Victoria’s
animal health personnel within seven days of identification.
Based on test type, the PCR segment has established a
dominant position in the market. Several key factors are poised to stimulate
the growth of this segment. These include the swift uptake of testing and
diagnostic technologies, coupled with the expanding livestock population, which
is anticipated to further bolster market expansion. Additionally, PCR testing
is readily accessible in clinical immunology and microbiology laboratories,
offering superior sensitivity and the ability to detect infections earlier
compared to antibody tests. As an illustration, the Animal Health Diagnostic
Center (AHDC) offers a Johne's Direct Fecal PCR test.
For herds engaged in Johne's disease management
through treatment and testing, this particular test is accessible to veterinary
practitioners and is designed to transform individual cow or goat cultures. On
the other hand, the ELISA segment is projected to experience the most rapid
CAGR during the forecasted period, driven by the increasing adoption of
diagnostic tests. It is essential to note that ELISA tests can only be
conducted on individual samples and are not amenable to pooling.
Major companies operating in Global Johne’s
Disease Diagnostics Market are:
- PBD Biotech Ltd
- Zoetis Inc
- IDEXX Laboratories Inc
- ID VET
- Thermo Fisher Scientific Inc
- Vmrd Inc
- bioMerieux Inc
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The Global Johne's Disease Diagnostics Market is
undergoing a transformative phase, with emerging trends that promise to reshape
the landscape. These trends include the adoption of NGS technology, the development
of point-of-care tests, advancements in serological assays and biomarkers,
digitalization, multiplex assays, targeted regional solutions, and a holistic
One Health approach. As the industry continues to innovate, these trends are
poised to drive improvements in disease detection, management, and prevention,
ultimately benefiting livestock health and food safety worldwide. Stakeholders
in the Johne's Disease Diagnostics Market must remain agile and
forward-thinking to harness the potential of these upcoming trends,” said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Johne’s Disease Diagnostics Market By Animal
Type (Cattle, Goat, Sheep), By Test Type (ELISA, PCR, AGID, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Johne’s Disease Diagnostics Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Johne’s Disease Diagnostics Market.
Contact
Mr. Ken Mathews
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel:
+13322586602
Email:
[email protected]
Website:
www.techsciresearch.com